Friday, November 22, 2024
HomeTagsLung Cancer Therapy

Lung Cancer Therapy

BerGenBio Partners with Tempus for STK11m Lung Cancer Therapy

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced a collaboration with Tempus, a technology...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics